Lessons from step-bd for the treatment of bipolar depression

Depression and Anxiety

Volumn 26, Issue 2, 2009, Pages 106-109

  Nierenberg, Andrew A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; FLUOXETINE PLUS OLANZAPINE; LAMOTRIGINE; PAROXETINE;

ARTICLE; BEHAVIOR THERAPY; BIPOLAR DEPRESSION; BIPOLAR II DISORDER; CLINICAL RESEARCH; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MONOTHERAPY; PRIORITY JOURNAL; SOCIAL PHOBIA; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 63849308566     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20547     Document Type: Article

References (23)

1. Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:537.
2. Judd LL, Schettler PJ, Akiskal HS et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry 2008;65:394.
3. Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G. Treatment of bipolar depression: an update. J Affect Disord 2008;109:21-34.
4. Möller HJ, Grunze H, Broich K. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? Eur Arch Psychiatry Clin Neurosci 2006;256:1-16.
5. Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar i depression. Arch Gen Psychiatry 2003;60:1079-1088.
6. Calabrese JR, Keck PE, Macfadden W et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-1360.
7. Thase ME. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study(The BOLDER II study)(vol 26, pg 600, 2006). J Clin Psychopharmacol 2007;27:51-51.
8. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88.
9. Calabrese JR, Huffman RF, White RL et al. Lamotrigine in the acute treatment of bipolar depression: results of five doubleblind, placebo-controlled clinical trials. Bipolar Disord 2008;10: 323-333.
10. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar i disorder. Arch Gen Psychiatry 2003;60:392-400.
11. Calabrese JR, Bowden CL, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-1024.
12. Sachs GS, Thase ME, Otto MW et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder(STEP-BD). Biol Psychiatry 2003;53(11):1028-1042.
13. Nierenberg AA, Ostacher MJ, Borrelli DJ et al. The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry 2006;67:3-7.
14. Perlis RH, Ostacher MJ, Patel JK et al. Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder(STEP-BD). Am J Psychiatry 2006;163:217-224.
15. Goldberg JF, Perlis RH, Ghaemi SN et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms:findings from the STEP-BD. Am J Psychiatry 2007;164: 1348-1355.
16. Otto MW, Simon NM, Wisniewski SR et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 2006;189:20-25.
17. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med Apr 2007;356:1711-1722.
18. Lavori PW, Rush AJ, Wisniewski SR et al. Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry 2001;50:792-801.
19. Nierenberg AA, Ostacher MJ, Calabrese JR et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 2006;163:210-216.
20. Miklowitz DJ, Otto MW, Frank E et al. Psychosocial treatments for bipolar depression-a 1-year randomized trial from the systematic treatment enhancement program. Arch Gen Psychiatry 2007;64:419-427.
21. Miklowitz DJ, Otto MW, Frank E et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry2007;164:1340-1347.
22. Maina G, Albert U, Rosso G, Bogetto F. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, singleblind, pilot study. J Clin Psychiatry 2008;69:609-616.
23. Sklar P, Smoller JW, Fan J et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008.